Allkem General Discussion, page-4734

Goldman maintains Buy rating on AKE but reduces price target to $14.4 (from ~$15). Goldman's price target for PLS is now below their current share price. Yet still even on the results yesterday and with PLS shorted to like 16% AKE is continually smashed harder and recovers slower.

Goldman: "Perceived Argentina risk (which we expect is overdone), may also ease following federal elections. We remain Buy rated, where AKE's long-term organic growth optionality remains undervalued."